iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report)’s share price passed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $34.83 and traded as low as $34.25. iShares Neuroscience and Healthcare ETF shares last traded at $34.79, with a volume of 2,512 shares changing hands.
iShares Neuroscience and Healthcare ETF Stock Performance
The stock has a fifty day moving average of $33.82 and a 200 day moving average of $34.84. The company has a market capitalization of $6.87 million, a P/E ratio of 15.61 and a beta of 0.80.
iShares Neuroscience and Healthcare ETF Company Profile
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.
Featured Stories
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
